Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Radiologists have been called to communicate directly with patients in order to raise visibility for the specialty and improve care for patients. One Florida breast imaging center is taking this idea to heart.
Pennsylvania Gov. Tom Wolf announced additional charges for tomosynthesis would no longer be assessed to patients in the state. In response, the editorial board of the Reading Eagle newspaper gave the move “an absolute thumbs-up.”
Efforts to curb the overutilization of imaging have been a topic of discussion for a number of years, spurred by the growth of imaging in the mid-2000s. But what can’t be forgotten is the value imaging brings to patient care.
Another study has found reduced recall rates, along with increased cancer detection, for patients who undergo 3D digital breast tomosynthesis (DBT) rather than standard 2D mammography at screening.
Visbion are delighted to announce that they have developed a new and innovative solution for the national breast screening programme. The service provides transfer of digital images; a real-time worklist on the x-ray unit in the van and live access to the Trust NBSS system.
An innovative, seven-minute MR scanning technique using no contrast has shown promise in ruling out malignancy—and thus averting unneeded biopsies—when deployed after regular screening mammography brings back troubling lesions.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
